K022331

Substantially Equivalent

ADVIA 120 HEMATOLOGY SYSTEM, CEREBROSPINAL FLUID METHOD

Applicant: Bayer Diagnostics Corp.
Product code: GKL
Advisory panel: Hematology
Date received: 2002-07-18
Decision date: 2002-09-11
Decision: Substantially Equivalent
Clearance type: Special
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.